Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010;16(27):2948-9.
doi: 10.2174/138161210793563572.

Bisphosphonates and bone diseases: past, present and future

Dominique Heymann
Editorial

Bisphosphonates and bone diseases: past, present and future

Dominique Heymann. Curr Pharm Des. 2010.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Francis MD, Velent DJ. Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases. J Musculoskeletal Neuronal Interact. 2007;7:2–8. - PubMed
    1. Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP. Bisphosphonates: Molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des. 2010 - PubMed
    1. Dunford JE. The molecular target of nitrogen containing bisphosphonates: the molecular pharmacology of FPP synthase. Curr Phram Des. 2010 - PubMed
    1. Mitrofan LM, Auriola S, Mönkkönen H, Mönkkönen J. Assessment of bishosphonate activity in vitro. Curr Pharm Des. 2010 - PubMed
    1. Moriceau G, Ory B, Gobin B, Verrecchia F, Gouin F, Blanchard F, Rédini F, Heymann D. Therapeutic approach of primary bone tumours by bisphosphonates. Curr Pharm Des. 2010 - PubMed

Publication types

MeSH terms

Substances